Also Ken, I think FcRn & Latch based trials, is why they kept Cytodyn in business through what appeared to be to us, rough waters.

Those programs have already been on-going for almost 2 years.

Oncology, inflammation, etc., is with our known data.
We can build with what we, control.

A "back-up" plan to FcRn, fetus, pregnancy, breastfeeding & Latch, if you will.